Acacia Research Corporation (ACTG) - Net Assets
Based on the latest financial reports, Acacia Research Corporation (ACTG) has net assets worth $567.23 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($755.87 Million) and total liabilities ($188.65 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Acacia Research Corporation tangible equity quality to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $567.23 Million |
| % of Total Assets | 75.04% |
| Annual Growth Rate | 17.97% |
| 5-Year Change | 35.67% |
| 10-Year Change | 118.38% |
| Growth Volatility | 60.35 |
Acacia Research Corporation - Net Assets Trend (1995–2025)
This chart illustrates how Acacia Research Corporation's net assets have evolved over time, based on quarterly financial data. See Acacia Research Corporation (ACTG) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Acacia Research Corporation (1995–2025)
The table below shows the annual net assets of Acacia Research Corporation from 1995 to 2025. For live valuation and market cap data, see ACTG market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $584.03 Million | +5.68% |
| 2024-12-31 | $552.62 Million | -6.27% |
| 2023-12-31 | $589.61 Million | +118.92% |
| 2022-12-31 | $269.32 Million | -37.44% |
| 2021-12-31 | $430.48 Million | +47.16% |
| 2020-12-31 | $292.53 Million | +67.20% |
| 2019-12-31 | $174.96 Million | -8.51% |
| 2018-12-31 | $191.24 Million | -35.32% |
| 2017-12-31 | $295.66 Million | +10.55% |
| 2016-12-31 | $267.44 Million | -14.87% |
| 2015-12-31 | $314.15 Million | -35.76% |
| 2014-12-31 | $489.05 Million | -13.01% |
| 2013-12-31 | $562.20 Million | -9.10% |
| 2012-12-31 | $618.48 Million | +92.01% |
| 2011-12-31 | $322.11 Million | +182.92% |
| 2010-12-31 | $113.85 Million | +103.42% |
| 2009-12-31 | $55.97 Million | -4.40% |
| 2008-12-31 | $58.55 Million | -9.66% |
| 2007-12-31 | $64.80 Million | +5.38% |
| 2006-12-31 | $61.49 Million | -1.21% |
| 2005-12-31 | $62.25 Million | +110.39% |
| 2004-12-31 | $29.59 Million | -17.33% |
| 2003-12-31 | $35.79 Million | -14.84% |
| 2002-12-31 | $42.03 Million | -28.44% |
| 2001-12-31 | $58.73 Million | -2.35% |
| 2000-12-31 | $60.14 Million | +32.88% |
| 1999-12-31 | $45.26 Million | +152.28% |
| 1998-12-31 | $17.94 Million | +113.40% |
| 1997-12-31 | $8.41 Million | +84.55% |
| 1996-12-31 | $4.56 Million | +10.97% |
| 1995-12-31 | $4.11 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Acacia Research Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 69185.3% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $96.00K | 0.02% |
| Other Comprehensive Income | $670.00K | 0.12% |
| Other Components | $796.79 Million | 146.62% |
| Total Equity | $543.45 Million | 100.00% |
Acacia Research Corporation Competitors by Market Cap
The table below lists competitors of Acacia Research Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sandhar Technologies Limited
NSE:SANDHAR
|
$448.46 Million |
|
Alexander Marine Co Ltd
TW:8478
|
$448.54 Million |
|
Sichuan Fulin Transportation Group Co Ltd
SHE:002357
|
$448.64 Million |
|
Iteos Therapeutics Inc
NASDAQ:ITOS
|
$448.68 Million |
|
Henan Qingshuiyuan Technology Co Ltd
SHE:300437
|
$448.05 Million |
|
Medistim ASA
OL:MEDI
|
$448.03 Million |
|
PCL Technologies Inc
TW:4977
|
$447.92 Million |
|
AngioDynamics Inc
NASDAQ:ANGO
|
$447.90 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Acacia Research Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 514,825,000 to 543,450,000, a change of 28,625,000 (5.6%).
- Net income of 21,682,000 contributed positively to equity growth.
- Other comprehensive income increased equity by 1,850,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $21.68 Million | +3.99% |
| Other Comprehensive Income | $1.85 Million | +0.34% |
| Other Changes | $5.09 Million | +0.94% |
| Total Change | $- | 5.56% |
Book Value vs Market Value Analysis
This analysis compares Acacia Research Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.84x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 22.43x to 0.84x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1995-12-31 | $0.21 | $4.68 | x |
| 1996-12-31 | $0.23 | $4.68 | x |
| 1997-12-31 | $0.42 | $4.68 | x |
| 1998-12-31 | $0.91 | $4.68 | x |
| 1999-12-31 | $4.16 | $4.68 | x |
| 2000-12-31 | $3.68 | $4.68 | x |
| 2001-12-31 | $3.05 | $4.68 | x |
| 2002-12-31 | $2.06 | $4.68 | x |
| 2003-12-31 | $1.76 | $4.68 | x |
| 2004-12-31 | $1.46 | $4.68 | x |
| 2005-12-31 | $2.32 | $4.68 | x |
| 2006-12-31 | $2.23 | $4.68 | x |
| 2007-12-31 | $2.27 | $4.68 | x |
| 2008-12-31 | $1.99 | $4.68 | x |
| 2009-12-31 | $1.87 | $4.68 | x |
| 2010-12-31 | $3.25 | $4.68 | x |
| 2011-12-31 | $7.97 | $4.68 | x |
| 2012-12-31 | $13.00 | $4.68 | x |
| 2013-12-31 | $11.67 | $4.68 | x |
| 2014-12-31 | $9.77 | $4.68 | x |
| 2015-12-31 | $6.35 | $4.68 | x |
| 2016-12-31 | $5.34 | $4.68 | x |
| 2017-12-31 | $5.83 | $4.68 | x |
| 2018-12-31 | $3.83 | $4.68 | x |
| 2019-12-31 | $3.44 | $4.68 | x |
| 2020-12-31 | $5.09 | $4.68 | x |
| 2021-12-31 | $4.26 | $4.68 | x |
| 2022-12-31 | $2.82 | $4.68 | x |
| 2023-12-31 | $6.15 | $4.68 | x |
| 2024-12-31 | $5.19 | $4.68 | x |
| 2025-12-31 | $5.59 | $4.68 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Acacia Research Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.99%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.60%
- • Asset Turnover: 0.37x
- • Equity Multiplier: 1.42x
- Recent ROE (3.99%) is above the historical average (-11.50%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1995 | 50.39% | 64.60% | 0.72x | 1.09x | $1.65 Million |
| 1996 | 9.36% | 13.16% | 0.60x | 1.18x | $-29.12K |
| 1997 | -34.96% | -662.23% | 0.05x | 1.08x | $-3.68 Million |
| 1998 | -34.50% | -1620.16% | 0.02x | 1.10x | $-7.98 Million |
| 1999 | -18.11% | -6718.85% | 0.00x | 1.14x | $-12.72 Million |
| 2000 | -64.78% | -68349.12% | 0.00x | 1.64x | $-44.97 Million |
| 2001 | -37.92% | -90.40% | 0.22x | 1.89x | $-28.15 Million |
| 2002 | -31.46% | -29660.47% | 0.00x | 1.16x | $-16.81 Million |
| 2003 | -15.73% | -787.72% | 0.02x | 1.15x | $-8.92 Million |
| 2004 | -19.24% | -129.39% | 0.13x | 1.15x | $-8.42 Million |
| 2005 | -10.15% | -32.06% | 0.28x | 1.11x | $-12.46 Million |
| 2006 | -8.94% | -15.78% | 0.53x | 1.07x | $-11.65 Million |
| 2007 | -23.83% | -29.36% | 0.74x | 1.10x | $-21.93 Million |
| 2008 | -23.50% | -28.53% | 0.66x | 1.25x | $-19.61 Million |
| 2009 | -20.17% | -16.77% | 0.86x | 1.40x | $-16.89 Million |
| 2010 | 29.91% | 25.83% | 0.98x | 1.18x | $22.67 Million |
| 2011 | 6.24% | 11.60% | 0.49x | 1.10x | $-12.02 Million |
| 2012 | 9.61% | 23.71% | 0.37x | 1.08x | $-2.39 Million |
| 2013 | -10.04% | -43.23% | 0.22x | 1.06x | $-112.65 Million |
| 2014 | -13.50% | -50.45% | 0.24x | 1.10x | $-114.93 Million |
| 2015 | -50.94% | -127.99% | 0.36x | 1.11x | $-191.45 Million |
| 2016 | -20.22% | -35.41% | 0.52x | 1.11x | $-80.81 Million |
| 2017 | 7.50% | 33.91% | 0.21x | 1.04x | $-7.39 Million |
| 2018 | -54.92% | -79.87% | 0.59x | 1.17x | $-124.15 Million |
| 2019 | -9.78% | -152.19% | 0.05x | 1.25x | $-34.61 Million |
| 2020 | 37.34% | 366.77% | 0.06x | 1.76x | $79.98 Million |
| 2021 | 35.57% | 169.45% | 0.11x | 1.90x | $107.25 Million |
| 2022 | -48.42% | -211.18% | 0.12x | 1.87x | $-150.89 Million |
| 2023 | 11.80% | 53.60% | 0.20x | 1.11x | $10.23 Million |
| 2024 | -7.00% | -29.48% | 0.16x | 1.47x | $-87.54 Million |
| 2025 | 3.99% | 7.60% | 0.37x | 1.42x | $-32.66 Million |
Industry Comparison
This section compares Acacia Research Corporation's net assets metrics with peer companies in the Business Equipment & Supplies industry.
Industry Context
- Industry: Business Equipment & Supplies
- Average net assets among peers: $4,425,810,667
- Average return on equity (ROE) among peers: 5.50%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Acacia Research Corporation (ACTG) | $567.23 Million | 50.39% | 0.33x | $448.17 Million |
| Acco Brands Corporation (ACCO) | $787.00 Million | -2.77% | 2.36x | $365.34 Million |
| Ennis Inc (EBF) | $331.43 Million | 14.27% | 0.19x | $518.76 Million |
| Xerox Corp (XRX) | $12.16 Billion | 4.98% | 1.52x | $430.26 Million |
About Acacia Research Corporation
Acacia Research Corporation operates as an acquirer and operator of businesses across industrial, energy, and technology sectors in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. It operates through four segments: Intellectual Property Operations, Industrial Operations, Energy Operations, and Manufacturing Operations. The company is involved in investing in IP; and licensing… Read more